Lenalidomide: a new treatment option for Castleman disease

Leuk Lymphoma. 2012 Oct;53(10):2089-91. doi: 10.3109/10428194.2011.621564. Epub 2011 Dec 5.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Castleman Disease / diagnosis
  • Castleman Disease / drug therapy*
  • Humans
  • Lenalidomide
  • Lymph Nodes / pathology
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Positron-Emission Tomography
  • Thalidomide / analogs & derivatives*
  • Thalidomide / therapeutic use
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Thalidomide
  • Lenalidomide